AzTrials
AzTrials

Postoperative PainNCT06744166

Effect of Transcutaneous Electrical Nerve Stimulation Based on Wrist-ankle Acupuncture Theory on Postoperative Pain After Video-assisted Thoracoscopic Surgery

A study testing TENS-WAA in people with Postoperative Pain and Video-assisted Thoracoscopic Surgery (VATS), run by Changhai Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

At present, surgical resection remains one of the main methods for the radical treatment of lung cancer. Compared with traditional thoracotomy, Video-assisted Thoracoscopic Surgery (VATS) offers obvious advantages, such as less surgical trauma and rapid postoperative recovery. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
TENS-WAA
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
156 participants
Where
1 siteChina
Study dates
6 Feb 2025to 20 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged over 18 years
  • American Society of Anesthesiologists (ASA) physical status of I-III
  • Patients scheduled for elective unilateral lobectomy via video-assisted thoracoscopic surgery (VATS) for lung cancer under general anesthesia
  • Informed consent signed

Who cannot join

  • History of liver, kidney, heart, lung, or brain disease
  • Psychiatric disorder or cognitive impairment
  • Chronic pain, daily use of analgesics, or alcohol dependence
  • Routine or recent acupuncture treatment
  • Contraindications to TENS (with pacemaker or metallic implants, allergy to surface electrodes, with skin sensory disorders, skin ulceration, unhealed scars, or adhesions)

Trial locations and contacts

1 site in 1 country.

China1 site
  • Changhai hospital

    Shanghai, Shanghai Municipality, 200090

Other trials in China

About this study

At present, surgical resection remains one of the main methods for the radical treatment of lung cancer. Compared with traditional thoracotomy, Video-assisted Thoracoscopic Surgery (VATS) offers obvious advantages, such as less surgical trauma and rapid postoperative recovery. However, a certain proportion of patients will still experience moderate to severe pain after undergoing VATS. Postoperative acute pain can lead to increased postoperative pulmonary complications, prolonged hospital stays, and increased treatment costs. Additionally, it is also associated with the development of postoperative chronic pain. Therefore, effective pain management after VATS is crucial.

Researchers will compare Transcutaneous Electrical Nerve Stimulation (TENS) based on Wrist-Ankle Acupuncture theory (TENS-WAA) with a sham stimulation regimen to determine whether TENS-WAA can relieve postoperative pain in patients undergoing thoracoscopic lung resection. This study aims to enrich the existing postoperative analgesia schemes and provide a reliable basis for its clinical promotion.

Being tested
TENS-WAA, Sham (No Treatment)
Keywords
Video-assisted thoracoscopic surgery (VATS), Postoperative pain
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TENS-WAADevice

    Patients assigned to the TENS-WAA group will receive transcutaneous electrical nerve stimulation based on Wrist-Ankle Acupuncture theory for a duration of 30 minutes after anesthesia induction, as well as at 8 hours and 24 hours postoperatively. According to the principles of WAA, two pairs of TENS-WAA (Wuxi Jiajian Medical Device Co., Ltd.) electrode pads will be placed on the upper area 2 and 3 with the skin of the treatment area exposed, and the upper and lower juxtaposition method will be adopted. Upper area 2 is at the middle of the palmar side of the forearm, between the palmaris longus and flexor carpi radialis. Upper area 3 is between the edge of the radius and the radial artery. Stimulation parameters of TENS-WAA are alternating dense-disperse wave with a frequency of 2Hz and a pulse width of 200μs, and a frequency of 100Hz with a pulse width of 150μs, alternating every 3 seconds ,intensity required to reach the maximum tolerable level without causing pain.

  • Sham (No Treatment)Device

    Patients assigned to the sham TENS-WAA group will receive sham stimulation for a duration of 30 minutes after anesthesia induction, as well as at 8 hours and 24 hours postoperatively. Researchers will attach the electrode patches at the same location, set the parameters to the same frequency, pulse width, and minimum current intensity as the TENS-WAA group, but do not activate the device, leaving it in place for 30 minutes at each time point.

Study groups in NCT06744166
Study groupRoleWhat they receive
TENS-WAA groupExperimentalPatients assigned to the TENS-WAA group will receive transcutaneous electrical nerve stimulation (TENS) based on Wrist-Ankle Acupuncture theory (WAA) for a duration of 30 minutes after anesthesia induction, as well as at 8 hours and 24 hours postoperatively.
Receives: Device: TENS-WAA
sham TENS-WAA groupSham comparatorPatients assigned to the sham TENS-WAA group will receive sham stimulation (without stimulation)for a duration of 30 minutes after anesthesia induction, as well as at 8 hours and 24 hours postoperatively.
Receives: Device: Sham (No Treatment)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The dynamic VAS score

    Independent investigators will assess the postoperative dynamic pain (pain during activities or coughing) by utilizing a visual analogue scale (VAS) ranging from 0 to 10. The two ends of the straight line represent "no pain at all" and "the worst pain imaginable," respectively. Patients are required to mark their corresponding position on the line based on their perception of pain, and the numerical value corresponding to this position serves as the patient's pain score.

    Measured: at 24 hours after surgery

Secondary outcomes (10)
  1. The static VAS score

    Postoperative static pain (pain at rest) will be quantified using the VAS.

    Measured: at 6 hours, 12 hours, 24 hours and 48 hours after surgery

  2. The dynamic VAS score

    Postoperative dynamic pain (pain during activities or coughing) will be quantified using the VAS.

    Measured: at 6 hours, 12 hours and 48 hours after surgery

  3. Opioid consumption during surgery

    The consumption of opioids during the surgery will be converted into morphine equivalent, and then the total will be calculated.

    Measured: at the end of the surgery

  4. Postoperative opioid consumption

    The consumption of opioids within 48 hours after surgery will be converted into morphine equivalent.

    Measured: at 48 hours after surgery

  5. Consumption of NSAIDs

    The consumption of Non-steroidal Anti-inflammatory Drugs within 48 hours after surgery will be recorded.

    Measured: at 48 hours after surgery

  6. The 15-item QoR score

    The 15-item QoR score is used to assess the quality of recovery after surgery, which ranges from 0 to 150, and higher QoR-15 scores indicate better postoperative recovery.

    Measured: at 24 hours and 48 hours after surgery

  7. The HADS score

    The Hospital Anxiety and Depression Scale (HADS) is used to evaluate patients' anxiety and depression. Scores on the HADS range from 0 to 21, and higher scores indicate more severe anxiety or depression.

    Measured: at 24 hours and 48 hours after surgery

  8. The AIS score

    The Athens Insomnia Scale (AIS) is used to assess the quality of sleep after surgery. Scores on the AIS range from 0 to 24, and higher scores indicate worse sleep quality.

    Measured: The morning of the first day after surgery and the morning of the second day after surgery.

  9. Incidence of PONV

    The researchers will observe whether patients experience nausea and vomiting after surgery.

    Measured: at 48 hours after surgery

  10. The duration of hospital stay

    The period from the end of surgery to the patient's discharge from the hospital will be recorded.

    Measured: on the 1 day of the patient's discharge from the hospital

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2024
  2. Study start6 Feb 2025
  3. Primary completion20 Jun 2025
  4. Study completion20 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
156 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06744166
Sponsor's protocol ID
TENS-WAA-VATS
Status last verified
Dec 2025
First submitted
15 Dec 2024
Last updated
31 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing TENS-WAA in people with Postoperative Pain and Video-assisted Thoracoscopic Surgery (VATS), run by Changhai Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The dynamic VAS score (time frame: at 24 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in